Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study

This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder (AUD). Participants were recruited from a phase II, randomized, double-blind, placebo-controlled clinical trial investigating psilocybin-assisted therapy...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 14; no. 1; p. 3159
Main Authors Pagni, B. A., Petridis, P. D., Podrebarac, S. K., Grinband, J., Claus, E. D., Bogenschutz, M. P.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 07.02.2024
Nature Publishing Group
Nature Portfolio
Subjects
631/1647/245/1627
631/378/3920
692/308/2779/777
Alcohol use
Alcohols
Brain mapping
Cerebellum
Clinical trials
Cortex (parietal)
Diphenhydramine
Emotions
Functional magnetic resonance imaging
Hippocampus
Humanities and Social Sciences
Magnetic resonance imaging
multidisciplinary
NCT
NCT02061293
Neuroimaging
Occipital lobe
Patients
Pilot projects
Prefrontal cortex
Psilocybin
Science
Science (multidisciplinary)
Temporal lobe
Online AccessGet full text

Cover

Abstract This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder (AUD). Participants were recruited from a phase II, randomized, double-blind, placebo-controlled clinical trial investigating psilocybin-assisted therapy (PAT) for the treatment of AUD (NCT02061293). Eleven adult patients completed task-based blood oxygen dependent functional magnetic resonance imaging (fMRI) approximately 3 days before and 2 days after receiving 25 mg of psilocybin (n = 5) or 50 mg of diphenhydramine (n = 6). Visual alcohol and emotionally valanced (positive, negative, or neutral) stimuli were presented in block design. Across both alcohol and emotional cues, psilocybin increased activity in the medial and lateral prefrontal cortex (PFC) and left caudate, and decreased activity in the insular, motor, temporal, parietal, and occipital cortices, and cerebellum. Unique to negative cues, psilocybin increased supramarginal gyrus activity; unique to positive cues, psilocybin increased right hippocampus activity and decreased left hippocampus activity. Greater PFC and caudate engagement and concomitant insula, motor, and cerebellar disengagement suggests enhanced goal-directed action, improved emotional regulation, and diminished craving. The robust changes in brain activity observed in this pilot study warrant larger neuroimaging studies to elucidate neural mechanisms of PAT. Trial registration : NCT02061293.
AbstractList This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder (AUD). Participants were recruited from a phase II, randomized, double-blind, placebo-controlled clinical trial investigating psilocybin-assisted therapy (PAT) for the treatment of AUD (NCT02061293). Eleven adult patients completed task-based blood oxygen dependent functional magnetic resonance imaging (fMRI) approximately 3 days before and 2 days after receiving 25 mg of psilocybin (n = 5) or 50 mg of diphenhydramine (n = 6). Visual alcohol and emotionally valanced (positive, negative, or neutral) stimuli were presented in block design. Across both alcohol and emotional cues, psilocybin increased activity in the medial and lateral prefrontal cortex (PFC) and left caudate, and decreased activity in the insular, motor, temporal, parietal, and occipital cortices, and cerebellum. Unique to negative cues, psilocybin increased supramarginal gyrus activity; unique to positive cues, psilocybin increased right hippocampus activity and decreased left hippocampus activity. Greater PFC and caudate engagement and concomitant insula, motor, and cerebellar disengagement suggests enhanced goal-directed action, improved emotional regulation, and diminished craving. The robust changes in brain activity observed in this pilot study warrant larger neuroimaging studies to elucidate neural mechanisms of PAT.Trial registration: NCT02061293.
This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder (AUD). Participants were recruited from a phase II, randomized, double-blind, placebo-controlled clinical trial investigating psilocybin-assisted therapy (PAT) for the treatment of AUD (NCT02061293). Eleven adult patients completed task-based blood oxygen dependent functional magnetic resonance imaging (fMRI) approximately 3 days before and 2 days after receiving 25 mg of psilocybin (n = 5) or 50 mg of diphenhydramine (n = 6). Visual alcohol and emotionally valanced (positive, negative, or neutral) stimuli were presented in block design. Across both alcohol and emotional cues, psilocybin increased activity in the medial and lateral prefrontal cortex (PFC) and left caudate, and decreased activity in the insular, motor, temporal, parietal, and occipital cortices, and cerebellum. Unique to negative cues, psilocybin increased supramarginal gyrus activity; unique to positive cues, psilocybin increased right hippocampus activity and decreased left hippocampus activity. Greater PFC and caudate engagement and concomitant insula, motor, and cerebellar disengagement suggests enhanced goal-directed action, improved emotional regulation, and diminished craving. The robust changes in brain activity observed in this pilot study warrant larger neuroimaging studies to elucidate neural mechanisms of PAT.Trial registration: NCT02061293.
Abstract This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder (AUD). Participants were recruited from a phase II, randomized, double-blind, placebo-controlled clinical trial investigating psilocybin-assisted therapy (PAT) for the treatment of AUD (NCT02061293). Eleven adult patients completed task-based blood oxygen dependent functional magnetic resonance imaging (fMRI) approximately 3 days before and 2 days after receiving 25 mg of psilocybin (n = 5) or 50 mg of diphenhydramine (n = 6). Visual alcohol and emotionally valanced (positive, negative, or neutral) stimuli were presented in block design. Across both alcohol and emotional cues, psilocybin increased activity in the medial and lateral prefrontal cortex (PFC) and left caudate, and decreased activity in the insular, motor, temporal, parietal, and occipital cortices, and cerebellum. Unique to negative cues, psilocybin increased supramarginal gyrus activity; unique to positive cues, psilocybin increased right hippocampus activity and decreased left hippocampus activity. Greater PFC and caudate engagement and concomitant insula, motor, and cerebellar disengagement suggests enhanced goal-directed action, improved emotional regulation, and diminished craving. The robust changes in brain activity observed in this pilot study warrant larger neuroimaging studies to elucidate neural mechanisms of PAT. Trial registration: NCT02061293.
Abstract This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder (AUD). Participants were recruited from a phase II, randomized, double-blind, placebo-controlled clinical trial investigating psilocybin-assisted therapy (PAT) for the treatment of AUD (NCT02061293). Eleven adult patients completed task-based blood oxygen dependent functional magnetic resonance imaging (fMRI) approximately 3 days before and 2 days after receiving 25 mg of psilocybin (n = 5) or 50 mg of diphenhydramine (n = 6). Visual alcohol and emotionally valanced (positive, negative, or neutral) stimuli were presented in block design. Across both alcohol and emotional cues, psilocybin increased activity in the medial and lateral prefrontal cortex (PFC) and left caudate, and decreased activity in the insular, motor, temporal, parietal, and occipital cortices, and cerebellum. Unique to negative cues, psilocybin increased supramarginal gyrus activity; unique to positive cues, psilocybin increased right hippocampus activity and decreased left hippocampus activity. Greater PFC and caudate engagement and concomitant insula, motor, and cerebellar disengagement suggests enhanced goal-directed action, improved emotional regulation, and diminished craving. The robust changes in brain activity observed in this pilot study warrant larger neuroimaging studies to elucidate neural mechanisms of PAT. Trial registration : NCT02061293.
This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder (AUD). Participants were recruited from a phase II, randomized, double-blind, placebo-controlled clinical trial investigating psilocybin-assisted therapy (PAT) for the treatment of AUD (NCT02061293). Eleven adult patients completed task-based blood oxygen dependent functional magnetic resonance imaging (fMRI) approximately 3 days before and 2 days after receiving 25 mg of psilocybin (n = 5) or 50 mg of diphenhydramine (n = 6). Visual alcohol and emotionally valanced (positive, negative, or neutral) stimuli were presented in block design. Across both alcohol and emotional cues, psilocybin increased activity in the medial and lateral prefrontal cortex (PFC) and left caudate, and decreased activity in the insular, motor, temporal, parietal, and occipital cortices, and cerebellum. Unique to negative cues, psilocybin increased supramarginal gyrus activity; unique to positive cues, psilocybin increased right hippocampus activity and decreased left hippocampus activity. Greater PFC and caudate engagement and concomitant insula, motor, and cerebellar disengagement suggests enhanced goal-directed action, improved emotional regulation, and diminished craving. The robust changes in brain activity observed in this pilot study warrant larger neuroimaging studies to elucidate neural mechanisms of PAT. Trial registration : NCT02061293.
ArticleNumber 3159
Author Grinband, J.
Bogenschutz, M. P.
Pagni, B. A.
Podrebarac, S. K.
Petridis, P. D.
Claus, E. D.
Author_xml – sequence: 1
  givenname: B. A.
  surname: Pagni
  fullname: Pagni, B. A.
  organization: Department of Psychiatry, NYU Langone Center for Psychedelic Medicine, NYU Grossman School of Medicine
– sequence: 2
  givenname: P. D.
  surname: Petridis
  fullname: Petridis, P. D.
  organization: Department of Psychiatry, NYU Langone Center for Psychedelic Medicine, NYU Grossman School of Medicine
– sequence: 3
  givenname: S. K.
  surname: Podrebarac
  fullname: Podrebarac, S. K.
  organization: Department of Psychiatry, NYU Langone Center for Psychedelic Medicine, NYU Grossman School of Medicine
– sequence: 4
  givenname: J.
  surname: Grinband
  fullname: Grinband, J.
  organization: Departments of Psychiatry and Radiology, Columbia University Vagelos College of Physicians & Surgeons
– sequence: 5
  givenname: E. D.
  surname: Claus
  fullname: Claus, E. D.
  organization: Department of Biobehavioral Health, The Pennsylvania State University
– sequence: 6
  givenname: M. P.
  surname: Bogenschutz
  fullname: Bogenschutz, M. P.
  email: Michael.Bogenschutz@nyulangone.org
  organization: Department of Psychiatry, NYU Langone Center for Psychedelic Medicine, NYU Grossman School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38326432$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAUhiNUREvpC7BAltiwCfiWxGGDUMVlpCIQgrXlHNszHmXswXaK5g362PVMytCywBtb9nf-c_H_tDrxwZuqek7wa4KZeJM4aXpRY8rrhvZtV4tH1RnFvKkpo_Tk3vm0ukhpjcsqICf9k-qUCUZbzuhZdfMtuTHAbnC-dl5PYDSClfJLk5DzyJspqhFFoyC7a5d3KAekRgirMCLlNTKbkF3whYFpDtmq7IzPCf12eXVkp2SQdilEbeLbEonsl-8LtC25M0p50rtn1WOrxmQu7vbz6ufHDz8uP9dXXz8tLt9f1dBwkutGdENDuaAMiLU9BsVaCwKsMqoDMJSwAaBhrcagLek63FI-2NZyMlBLDDuvFrOuDmott9FtVNzJoJw8XIS4lCpmB6ORTacEPkRrxQc1iL4Tuh2gh85Sq5qi9W7W2k7DxmgobZdpPRB9-OLdSi7DtSRYNJh3oii8ulOI4VcZYJYbl8CMo_ImTEnSnrJ-_99tQV_-g67DFMvkZ4oIgruuUHSmIIaUorHHagiWeyE5G0eWxuTBOHJfxYv7fRxD_tikAGwGUnkq3oh_c_9H9hZ0jdNo
CitedBy_id crossref_primary_10_3389_fnins_2024_1420601
crossref_primary_10_1007_s40429_024_00581_z
Cites_doi 10.1146/annurev.clinpsy.1.102803.144107
10.1186/s13041-020-00605-5
10.1111/ajad.13170
10.1038/tp.2017.40
10.1111/j.1369-1600.2012.00464.x
10.1016/j.neubiorev.2021.06.031
10.1001/jama.2014.3628
10.1038/s41398-021-01706-y
10.1177/0269881114548296
10.3389/fphar.2022.884703
10.1016/j.neuroimage.2019.04.009
10.1037/abn0000503
10.1176/appi.ajp.2020.19070703
10.1037/adb0000935
10.1371/journal.pone.0046931
10.1111/add.13974
10.35946/arcr.v41.1.07
10.1177/0269881116675513
10.3389/fnhum.2018.00448
10.1111/nyas.12415
10.1016/j.neubiorev.2020.04.004
10.1177/0022167816673493
10.1016/j.bpsc.2019.10.005
10.1038/s41593-022-01228-w
10.1093/ijnp/pyac074
10.1016/j.nicl.2017.04.010
10.1007/s00213-017-4771-x
10.1111/j.1360-0443.2010.03022.x
10.1016/j.biopsych.2015.10.024
10.1177/0269881111420188
10.1111/acer.14614
10.1038/npp.2009.131
10.1007/s40265-021-01670-3
10.1007/s00213-019-05445-3
10.1016/j.drugalcdep.2015.10.036
10.1126/sciadv.aaw4358
10.1016/j.neuroimage.2005.12.002
10.1021/acsptsci.1c00020
10.1016/j.biopsych.2018.02.600
10.3389/fpsyg.2023.1104627
10.1016/j.pbb.2008.12.009
10.1016/j.neuroimage.2017.07.020
10.1016/j.biopsych.2012.04.005
10.1038/s41598-018-28274-4
10.1111/adb.12013
10.1177/0269881119895520
10.1016/j.drugalcdep.2014.05.017
10.1056/NEJMoa2206443
10.1111/acps.12904
10.1016/j.drugalcdep.2007.06.011
10.1016/j.eclinm.2022.101809
10.1016/j.bandc.2022.105843
10.3389/fnsys.2021.642225
10.3389/fphar.2021.721537
10.1001/jamapsychiatry.2022.2096
10.1017/S003329172000389X
10.1093/alcalc/agy093
10.1111/acer.14283
10.1001/jamapsychiatry.2013.762
10.1038/s41598-017-13282-7
10.1073/pnas.1007779107
10.3389/fphar.2018.00100
10.1111/j.1530-0277.1999.tb04349.x
10.1038/s41598-020-59282-y
10.1001/jamapsychiatry.2021.1271
10.1111/adb.12863
10.1016/j.bbr.2014.08.039
10.1016/j.drugalcdep.2019.107569.A
10.1177/0269881114565144
10.1016/S2215-0366(16)00104-8
10.1016/j.biopsych.2010.12.016
10.1177/0269881116675512
10.1111/j.1369-1600.2011.00352.x
10.1111/adb.12101
10.1016/j.neuroimage.2009.10.088.Cognitive
10.1101/2023.08.22.23294131
10.56441/hilbertpress.2207.6600
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
NPM
AAYXX
CITATION
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
Q9U
7X8
5PM
DOA
DOI 10.1038/s41598-024-52967-8
DatabaseName Springer Nature OA Free Journals
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Science Database
Biological Science Database
ProQuest - Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database
PubMed

CrossRef
Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 3159
ExternalDocumentID oai_doaj_org_article_57a8024bf6da4bab8978d6bc9c7f2fa5
10_1038_s41598_024_52967_8
38326432
Genre Journal Article
GrantInformation_xml – fundername: Heffter Research Institute (Heffter Research Institute Inc)
– fundername: Clinical and Translational Science Institute, New York University (CTSI)
  grantid: UL1 TR000038
– fundername: NCATS NIH HHS
  grantid: UL1 TR000038
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNT
RNTTT
RPM
SNYQT
UKHRP
NPM
AAYXX
AFPKN
CITATION
7XB
8FK
K9.
M48
PQEST
PQUKI
Q9U
7X8
5PM
ID FETCH-LOGICAL-c541t-587b524823c1ff90ca36fc8cfaea7cce213bcc536d0cdf1770624bf6f41b2f1e3
IEDL.DBID RPM
ISSN 2045-2322
IngestDate Tue Oct 22 15:16:29 EDT 2024
Tue Sep 17 21:29:59 EDT 2024
Fri Oct 25 07:52:19 EDT 2024
Sat Oct 26 16:57:10 EDT 2024
Fri Aug 23 03:14:57 EDT 2024
Sat Nov 02 12:30:08 EDT 2024
Fri Oct 11 20:46:52 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c541t-587b524823c1ff90ca36fc8cfaea7cce213bcc536d0cdf1770624bf6f41b2f1e3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10850478/
PMID 38326432
PQID 2923181077
PQPubID 2041939
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_57a8024bf6da4bab8978d6bc9c7f2fa5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10850478
proquest_miscellaneous_2923910386
proquest_journals_2923181077
crossref_primary_10_1038_s41598_024_52967_8
pubmed_primary_38326432
springer_journals_10_1038_s41598_024_52967_8
PublicationCentury 2000
PublicationDate 2024-02-07
PublicationDateYYYYMMDD 2024-02-07
PublicationDate_xml – month: 02
  year: 2024
  text: 2024-02-07
  day: 07
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2024
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Han, Jones, Einstein, Powell, Compton (CR13) 2021; 78
Kober (CR65) 2010; 107
Schacht, Anton, Myrick (CR53) 2013; 18
McKenna, Fedota, Garcia-Romeu, Johnson, Griffiths, Stein (CR29) 2018; 83
CR34
CR33
Chester, Lynam, Milich, DeWall (CR54) 2016; 163
Ju, Fernandez-Arroyo, Wu, Jacky, Beyeler (CR83) 2020; 13
Kragel, Reddan, LaBar, Wager (CR80) 2019
Murphy-Beiner, Soar (CR30) 2020; 237
Strosche (CR72) 2021; 26
Votaw, Pearson, Stein, Witkiewitz (CR3) 2020; 44
Voon (CR4) 2020; 113
Bogenschutz (CR32) 2018; 9
Erritzoe (CR26) 2018; 138
Beylergil (CR67) 2017; 15
Vollstädt-Klein (CR73) 2011; 69
Ross (CR22) 2016
Kähönen (CR36) 2023; 14
Lang, Bradley, Cuthbert (CR48) 1997; 1
Habas (CR75) 2021; 15
Al-Khalil, Vakamudi, Witkiewitz, Claus (CR6) 2021; 45
Kometer, Schmidt, Bachmann, Studerus, Seifritz, Vollenweider (CR17) 2012; 72
Mollick, Kober (CR56) 2020; 129
Ames (CR55) 2014; 274
Fujino, Ueda, Mizuhara, Saiki, Nomura (CR82) 2018; 8
CR49
Boggio (CR68) 2008; 92
Barrett, Doss, Sepeda, Pekar, Gri (CR41) 2020
Burnette (CR10) 2022; 82
Carhart-Harris (CR20) 2018; 235
CR45
CR44
Griffiths (CR21) 2016
Bogenschutz (CR16) 2022
Naqvi, Gaznick, Tranel, Bechara (CR76) 2014; 1316
Kiraga (CR31) 2021; 12
Seo, Lacadie, Tuit, Hong, Todd Constable, Sinha (CR60) 2013; 70
Kinley, Amlung, Becker (CR57) 2022
Vollstädt-Klein (CR7) 2012; 17
Zeng, Yu, Cao, Su, Dong, Yang (CR52) 2021; 128
Jonas (CR12) 2014; 311
Stohs, Schneekloth, Geske, Biernacka, Karpyak (CR9) 2019; 54
Smigielski, Scheidegger, Kometer, Vollenweider (CR37) 2019; 196
Mertens, Wall, Roseman, Demetriou, Nutt, Carhart-Harris (CR40) 2020; 34
Doss (CR28) 2021; 11
Bogenschutz, Forcehimes (CR43) 2017; 57
CR58
Kim, Han, Min, Kim, Cheong (CR63) 2014; 141
Sher, Grekin, Williams (CR1) 2005; 1
Goodwin (CR19) 2022; 387
Goldberg (CR25) 2020
Koban, Wager, Kober (CR79) 2022
Koob, Volkow (CR5) 2016; 3
CR50
Beraha (CR77) 2012; 7
Moulton, Elman, Becerra, Goldstein, Borsook (CR74) 2014; 19
Wise (CR38) 2017
Kwako, Momenan, Litten, Koob, Goldman (CR2) 2016; 80
Blaine (CR59) 2020; 177
Ross (CR24) 2021; 4
Courtney, Ghahremani, Ray (CR71) 2013; 18
Magalhaes, Oliveira, Pereira, Menezes (CR81) 2018
MacLean, Johnson, Griffiths (CR27) 2011; 25
Agin-Liebes (CR78) 2023
Flannery, Volpicelli, Pettinati (CR46) 1999; 23
Palpacuer (CR11) 2018; 113
Carhart-Harris (CR39) 2017; 7
Suzuki, Mell, O’Malley, Krystal, Anticevic, Kober (CR64) 2020; 5
Gattuso (CR69) 2023; 26
Johnson, Garcia-Romeu, Cosimano, Griffiths (CR23) 2014; 28
Vollstädt-Klein (CR47) 2010; 105
Bogenschutz, Forcehimes, Pommy, Wilcox, Barbosa, Strassman (CR15) 2015; 29
CR62
Hester, Garavan (CR66) 2009; 93
Wemm (CR8) 2020; 12
Northoff, Heinzel, de Greck, Bermpohl, Dobrowolny, Panksepp (CR61) 2006; 31
Balleine, O’Doherty (CR70) 2010; 35
Keyser-Marcus, Ramey, Bjork, Adams, Moeller (CR35) 2021; 30
Mason, Heyser (CR14) 2021; 41
Perkins, Pagni, Sarris, Barbosa, Chenhall (CR42) 2022
von Rotz (CR18) 2023; 56
Cr (CR51) 2017; 159
GF Koob (52967_CR5) 2016; 3
M Fujino (52967_CR82) 2018; 8
MK Kiraga (52967_CR31) 2021; 12
MP Bogenschutz (52967_CR16) 2022
I Kinley (52967_CR57) 2022
SB Beylergil (52967_CR67) 2017; 15
MP Bogenschutz (52967_CR15) 2015; 29
S Vollstädt-Klein (52967_CR47) 2010; 105
EA Moulton (52967_CR74) 2014; 19
D Perkins (52967_CR42) 2022
J Zeng (52967_CR52) 2021; 128
SM Kim (52967_CR63) 2014; 141
A Strosche (52967_CR72) 2021; 26
M McKenna (52967_CR29) 2018; 83
52967_CR62
MK Doss (52967_CR28) 2021; 11
L Cr (52967_CR51) 2017; 159
NH Naqvi (52967_CR76) 2014; 1316
DE Jonas (52967_CR12) 2014; 311
S Vollstädt-Klein (52967_CR7) 2012; 17
M Kometer (52967_CR17) 2012; 72
MP Bogenschutz (52967_CR32) 2018; 9
52967_CR58
BA Flannery (52967_CR46) 1999; 23
H Kober (52967_CR65) 2010; 107
V Voon (52967_CR4) 2020; 113
MW Johnson (52967_CR23) 2014; 28
PS Boggio (52967_CR68) 2008; 92
S Ross (52967_CR24) 2021; 4
AA Magalhaes (52967_CR81) 2018
52967_CR50
S Ross (52967_CR22) 2016
LJ Mertens (52967_CR40) 2020; 34
J Kähönen (52967_CR36) 2023; 14
GM Goodwin (52967_CR19) 2022; 387
DS Chester (52967_CR54) 2016; 163
BJ Mason (52967_CR14) 2021; 41
T Wise (52967_CR38) 2017
52967_CR45
52967_CR44
VR Votaw (52967_CR3) 2020; 44
52967_CR49
G Northoff (52967_CR61) 2006; 31
FS Barrett (52967_CR41) 2020
SK Blaine (52967_CR59) 2020; 177
A Ju (52967_CR83) 2020; 13
JJ Gattuso (52967_CR69) 2023; 26
E Beraha (52967_CR77) 2012; 7
S Vollstädt-Klein (52967_CR73) 2011; 69
RR Griffiths (52967_CR21) 2016
RL Carhart-Harris (52967_CR39) 2017; 7
C Palpacuer (52967_CR11) 2018; 113
JA Mollick (52967_CR56) 2020; 129
B Han (52967_CR13) 2021; 78
L Smigielski (52967_CR37) 2019; 196
G Agin-Liebes (52967_CR78) 2023
PA Kragel (52967_CR80) 2019
JP Schacht (52967_CR53) 2013; 18
R von Rotz (52967_CR18) 2023; 56
BW Balleine (52967_CR70) 2010; 35
LE Kwako (52967_CR2) 2016; 80
D Erritzoe (52967_CR26) 2018; 138
52967_CR34
KE Courtney (52967_CR71) 2013; 18
SE Wemm (52967_CR8) 2020; 12
SB Goldberg (52967_CR25) 2020
52967_CR33
S Suzuki (52967_CR64) 2020; 5
EM Burnette (52967_CR10) 2022; 82
LA Keyser-Marcus (52967_CR35) 2021; 30
MP Bogenschutz (52967_CR43) 2017; 57
PJ Lang (52967_CR48) 1997; 1
KA MacLean (52967_CR27) 2011; 25
SL Ames (52967_CR55) 2014; 274
C Habas (52967_CR75) 2021; 15
RL Carhart-Harris (52967_CR20) 2018; 235
KJ Sher (52967_CR1) 2005; 1
ME Stohs (52967_CR9) 2019; 54
R Hester (52967_CR66) 2009; 93
A Murphy-Beiner (52967_CR30) 2020; 237
D Seo (52967_CR60) 2013; 70
L Koban (52967_CR79) 2022
K Al-Khalil (52967_CR6) 2021; 45
References_xml – ident: CR45
– volume: 1
  start-page: 493
  year: 2005
  end-page: 523
  ident: CR1
  article-title: The development of alcohol use disorders
  publication-title: Annu. Rev. Clin. Psychol.
  doi: 10.1146/annurev.clinpsy.1.102803.144107
  contributor:
    fullname: Williams
– volume: 13
  start-page: 1
  issue: 1
  year: 2020
  end-page: 13
  ident: CR83
  article-title: Expression of serotonin 1A and 2A receptors in molecular- and projection- defined neurons of the mouse insular cortex
  publication-title: Mol. Brain
  doi: 10.1186/s13041-020-00605-5
  contributor:
    fullname: Beyeler
– volume: 30
  start-page: 398
  issue: 4
  year: 2021
  end-page: 405
  ident: CR35
  article-title: Development and feasibility study of an addiction-focused phenotyping assessment battery
  publication-title: Am. J. Addict.
  doi: 10.1111/ajad.13170
  contributor:
    fullname: Moeller
– year: 2017
  ident: CR38
  article-title: Instability of default mode network connectivity in major depression: A two-sample confirmation study
  publication-title: Transl. Psychiatry
  doi: 10.1038/tp.2017.40
  contributor:
    fullname: Wise
– volume: 18
  start-page: 121
  issue: 1
  year: 2013
  end-page: 133
  ident: CR53
  article-title: Functional neuroimaging studies of alcohol cue reactivity: A quantitative meta-analysis and systematic review
  publication-title: Addict. Biol.
  doi: 10.1111/j.1369-1600.2012.00464.x
  contributor:
    fullname: Myrick
– volume: 128
  start-page: 294
  year: 2021
  end-page: 310
  ident: CR52
  article-title: Neurobiological correlates of cue-reactivity in alcohol-use disorders: A voxel-wise meta-analysis of fMRI studies
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2021.06.031
  contributor:
    fullname: Yang
– ident: CR49
– volume: 311
  start-page: 1889
  issue: 18
  year: 2014
  end-page: 1900
  ident: CR12
  article-title: Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis
  publication-title: JAMA
  doi: 10.1001/jama.2014.3628
  contributor:
    fullname: Jonas
– volume: 11
  start-page: 1
  issue: 1
  year: 2021
  end-page: 10
  ident: CR28
  article-title: Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
  publication-title: Transl. Psychiatry
  doi: 10.1038/s41398-021-01706-y
  contributor:
    fullname: Doss
– volume: 28
  start-page: 983
  issue: 11
  year: 2014
  end-page: 992
  ident: CR23
  article-title: Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881114548296
  contributor:
    fullname: Griffiths
– year: 2022
  ident: CR42
  article-title: Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2022.884703
  contributor:
    fullname: Chenhall
– volume: 196
  start-page: 207
  year: 2019
  end-page: 215
  ident: CR37
  article-title: Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2019.04.009
  contributor:
    fullname: Vollenweider
– volume: 129
  start-page: 544
  issue: 6
  year: 2020
  end-page: 555
  ident: CR56
  article-title: Computational models of drug use and addiction: A review
  publication-title: J. Abnorm. Psychol.
  doi: 10.1037/abn0000503
  contributor:
    fullname: Kober
– volume: 177
  start-page: 1048
  issue: 11
  year: 2020
  end-page: 1059
  ident: CR59
  article-title: Association of prefrontal-striatal functional pathology with alcohol abstinence days at treatment initiation and heavy drinking after treatment initiation
  publication-title: Am. J. Psychiatry
  doi: 10.1176/appi.ajp.2020.19070703
  contributor:
    fullname: Blaine
– year: 2023
  ident: CR78
  article-title: Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis
  publication-title: Psychol. Addict. Behav.
  doi: 10.1037/adb0000935
  contributor:
    fullname: Agin-Liebes
– volume: 7
  start-page: 1
  issue: 10
  year: 2012
  end-page: 9
  ident: CR77
  article-title: Hemispheric asymmetry for affective stimulus processing in healthy subjects—A fMRI study
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0046931
  contributor:
    fullname: Beraha
– ident: CR58
– volume: 113
  start-page: 220
  issue: 2
  year: 2018
  end-page: 237
  ident: CR11
  article-title: Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: A systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate
  publication-title: Addiction
  doi: 10.1111/add.13974
  contributor:
    fullname: Palpacuer
– volume: 41
  start-page: 1
  issue: 1
  year: 2021
  end-page: 17
  ident: CR14
  article-title: Alcohol use disorder: The role of medication in recovery
  publication-title: Alcohol Res. Curr. Rev.
  doi: 10.35946/arcr.v41.1.07
  contributor:
    fullname: Heyser
– year: 2016
  ident: CR21
  article-title: Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881116675513
  contributor:
    fullname: Griffiths
– year: 2018
  ident: CR81
  article-title: Does meditation alter brain responses to negative stimuli? A systematic review
  publication-title: Front. Hum. Neurosci.
  doi: 10.3389/fnhum.2018.00448
  contributor:
    fullname: Menezes
– volume: 1316
  start-page: 53
  issue: 1
  year: 2014
  end-page: 70
  ident: CR76
  article-title: The insula: A critical neural substrate for craving and drug seeking under conflict and risk
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/nyas.12415
  contributor:
    fullname: Bechara
– volume: 113
  start-page: 492
  issue: March
  year: 2020
  end-page: 506
  ident: CR4
  article-title: Addictions NeuroImaging Assessment (ANIA): Towards an integrative framework for alcohol use disorder
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2020.04.004
  contributor:
    fullname: Voon
– volume: 57
  start-page: 389
  issue: 4
  year: 2017
  end-page: 414
  ident: CR43
  article-title: Development of a psychotherapeutic model for psilocybin-assisted treatment of alcoholism
  publication-title: J. Humanist. Psychol.
  doi: 10.1177/0022167816673493
  contributor:
    fullname: Forcehimes
– volume: 5
  start-page: 239
  issue: 2
  year: 2020
  end-page: 250
  ident: CR64
  article-title: Regulation of craving and negative emotion in alcohol use disorder
  publication-title: Biol. Psychiatry Cogn. Neurosci. Neuroimaging
  doi: 10.1016/j.bpsc.2019.10.005
  contributor:
    fullname: Kober
– year: 2022
  ident: CR79
  article-title: A neuromarker for drug and food craving distinguishes drug users from non-users
  publication-title: Nat. Neurosci.
  doi: 10.1038/s41593-022-01228-w
  contributor:
    fullname: Kober
– volume: 26
  start-page: 155
  issue: 3
  year: 2023
  end-page: 188
  ident: CR69
  article-title: Default mode network modulation by psychedelics: A systematic review
  publication-title: Int. J. Neuropsychopharmacol.
  doi: 10.1093/ijnp/pyac074
  contributor:
    fullname: Gattuso
– ident: CR50
– volume: 15
  start-page: 80
  year: 2017
  end-page: 94
  ident: CR67
  article-title: Dorsolateral prefrontal cortex contributes to the impaired behavioral adaptation in alcohol dependence
  publication-title: NeuroImage Clin.
  doi: 10.1016/j.nicl.2017.04.010
  contributor:
    fullname: Beylergil
– volume: 235
  start-page: 399
  year: 2018
  end-page: 408
  ident: CR20
  article-title: Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-017-4771-x
  contributor:
    fullname: Carhart-Harris
– volume: 105
  start-page: 1741
  issue: 10
  year: 2010
  end-page: 1749
  ident: CR47
  article-title: Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2010.03022.x
  contributor:
    fullname: Vollstädt-Klein
– volume: 80
  start-page: 179
  issue: 3
  year: 2016
  end-page: 189
  ident: CR2
  article-title: Addictions neuroclinical assessment: A neuroscience-based framework for addictive disorders
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2015.10.024
  contributor:
    fullname: Goldman
– volume: 25
  start-page: 1453
  issue: 11
  year: 2011
  end-page: 1461
  ident: CR27
  article-title: Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881111420188
  contributor:
    fullname: Griffiths
– volume: 45
  start-page: 1200
  issue: 6
  year: 2021
  end-page: 1214
  ident: CR6
  article-title: Neural correlates of alcohol use disorder severity among nontreatment-seeking heavy drinkers: An examination of the incentive salience and negative emotionality domains of the alcohol and addiction research domain criteria
  publication-title: Alcohol. Clin. Exp. Res.
  doi: 10.1111/acer.14614
  contributor:
    fullname: Claus
– volume: 35
  start-page: 48
  issue: 1
  year: 2010
  end-page: 69
  ident: CR70
  article-title: Human and rodent homologies in action control: Corticostriatal determinants of goal-directed and habitual action
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2009.131
  contributor:
    fullname: O’Doherty
– volume: 82
  start-page: 251
  issue: 3
  year: 2022
  end-page: 274
  ident: CR10
  article-title: Novel agents for the pharmacological treatment of alcohol use disorder
  publication-title: Drugs
  doi: 10.1007/s40265-021-01670-3
  contributor:
    fullname: Burnette
– volume: 237
  start-page: 1161
  issue: 4
  year: 2020
  end-page: 1169
  ident: CR30
  article-title: Ayahuasca’s ‘afterglow’: Improved mindfulness and cognitive flexibility in ayahuasca drinkers
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-019-05445-3
  contributor:
    fullname: Soar
– volume: 163
  start-page: S25
  year: 2016
  end-page: S28
  ident: CR54
  article-title: Craving versus control: Negative urgency and neural correlates of alcohol cue reactivity
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2015.10.036
  contributor:
    fullname: DeWall
– year: 2019
  ident: CR80
  article-title: Emotion schemas are embedded in the human visual system
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aaw4358
  contributor:
    fullname: Wager
– volume: 31
  start-page: 440
  issue: 1
  year: 2006
  end-page: 457
  ident: CR61
  article-title: Self-referential processing in our brain—a meta-analysis of imaging studies on the self
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2005.12.002
  contributor:
    fullname: Panksepp
– volume: 4
  start-page: 553
  issue: 2
  year: 2021
  end-page: 562
  ident: CR24
  article-title: Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening cancer
  publication-title: ACS Pharmacol. Transl. Sci.
  doi: 10.1021/acsptsci.1c00020
  contributor:
    fullname: Ross
– volume: 83
  start-page: S231
  issue: 9
  year: 2018
  end-page: S232
  ident: CR29
  article-title: T263. Psilocybin improves cognitive control and downregulates parietal cortex in treatment-seeking smokers
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2018.02.600
  contributor:
    fullname: Stein
– volume: 14
  start-page: 1
  issue: June
  year: 2023
  end-page: 20
  ident: CR36
  article-title: Psychedelic unselfing: Self-transcendence and change of values in psychedelic experiences
  publication-title: Front. Psychol.
  doi: 10.3389/fpsyg.2023.1104627
  contributor:
    fullname: Kähönen
– volume: 93
  start-page: 270
  issue: 3
  year: 2009
  end-page: 277
  ident: CR66
  article-title: Neural mechanisms underlying drug-related cue distraction in active cocaine users
  publication-title: Pharmacol. Biochem. Behav.
  doi: 10.1016/j.pbb.2008.12.009
  contributor:
    fullname: Garavan
– volume: 159
  start-page: 70
  year: 2017
  end-page: 78
  ident: CR51
  article-title: Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2017.07.020
  contributor:
    fullname: Cr
– volume: 72
  start-page: 898
  issue: 11
  year: 2012
  end-page: 906
  ident: CR17
  article-title: Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2012.04.005
  contributor:
    fullname: Vollenweider
– volume: 8
  start-page: 1
  issue: 1
  year: 2018
  end-page: 10
  ident: CR82
  article-title: Open monitoring meditation reduces the involvement of brain regions related to memory function
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-28274-4
  contributor:
    fullname: Nomura
– ident: CR33
– volume: 18
  start-page: 593
  issue: 3
  year: 2013
  end-page: 604
  ident: CR71
  article-title: Fronto-striatal functional connectivity during response inhibition in alcohol dependence
  publication-title: Addict. Biol.
  doi: 10.1111/adb.12013
  contributor:
    fullname: Ray
– volume: 34
  start-page: 167
  issue: 2
  year: 2020
  end-page: 180
  ident: CR40
  article-title: Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881119895520
  contributor:
    fullname: Carhart-Harris
– volume: 141
  start-page: 124
  year: 2014
  end-page: 131
  ident: CR63
  article-title: Brain activation in response to craving- and aversion-inducing cues related to alcohol in patients with alcohol dependence
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2014.05.017
  contributor:
    fullname: Cheong
– volume: 1
  start-page: 3
  issue: 39–58
  year: 1997
  ident: CR48
  article-title: International affective picture system (IAPS): Technical manual and affective ratings
  publication-title: NIMH Cent. Study Emot. Atten.
  contributor:
    fullname: Cuthbert
– volume: 387
  start-page: 1637
  issue: 18
  year: 2022
  end-page: 1648
  ident: CR19
  article-title: Single-dose psilocybin for a treatment-resistant episode of major depression
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2206443
  contributor:
    fullname: Goodwin
– volume: 138
  start-page: 368
  issue: 5
  year: 2018
  end-page: 378
  ident: CR26
  article-title: Effects of psilocybin therapy on personality structure
  publication-title: Acta Psychiatr. Scand.
  doi: 10.1111/acps.12904
  contributor:
    fullname: Erritzoe
– volume: 92
  start-page: 55
  issue: 1–3
  year: 2008
  end-page: 60
  ident: CR68
  article-title: Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: A double-blind, sham-controlled study
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2007.06.011
  contributor:
    fullname: Boggio
– ident: CR44
– volume: 56
  start-page: 101809
  year: 2023
  ident: CR18
  article-title: Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
  publication-title: eClinicalMedicine
  doi: 10.1016/j.eclinm.2022.101809
  contributor:
    fullname: von Rotz
– year: 2022
  ident: CR57
  article-title: Pathologies of precision: A Bayesian account of goals, habits, and episodic foresight in addiction
  publication-title: Brain Cogn.
  doi: 10.1016/j.bandc.2022.105843
  contributor:
    fullname: Becker
– volume: 15
  start-page: 1
  year: 2021
  end-page: 8
  ident: CR75
  article-title: Functional connectivity of the cognitive cerebellum
  publication-title: Front. Syst. Neurosci.
  doi: 10.3389/fnsys.2021.642225
  contributor:
    fullname: Habas
– volume: 12
  start-page: 1
  year: 2021
  end-page: 14
  ident: CR31
  article-title: Persisting effects of ayahuasca on empathy, creative thinking, decentering, personality, and well-being
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2021.721537
  contributor:
    fullname: Kiraga
– year: 2022
  ident: CR16
  article-title: Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: A randomized clinical trial
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2022.2096
  contributor:
    fullname: Bogenschutz
– year: 2020
  ident: CR25
  article-title: Post-acute psychological effects of classical serotonergic psychedelics: A systematic review and meta-analysis
  publication-title: Psychol. Med.
  doi: 10.1017/S003329172000389X
  contributor:
    fullname: Goldberg
– volume: 54
  start-page: 167
  issue: 2
  year: 2019
  end-page: 172
  ident: CR9
  article-title: Alcohol craving predicts relapse after residential addiction treatment
  publication-title: Alcohol Alcohol.
  doi: 10.1093/alcalc/agy093
  contributor:
    fullname: Karpyak
– volume: 44
  start-page: 679
  issue: 3
  year: 2020
  end-page: 688
  ident: CR3
  article-title: The addictions neuroclinical assessment negative emotionality domain among treatment-seekers with alcohol use disorder: Construct validity and measurement invariance
  publication-title: Alcohol. Clin. Exp. Res.
  doi: 10.1111/acer.14283
  contributor:
    fullname: Witkiewitz
– volume: 70
  start-page: 727
  issue: 7
  year: 2013
  end-page: 739
  ident: CR60
  article-title: Disrupted ventromedial prefrontal function, alcohol craving, and subsequent relapse risk
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.762
  contributor:
    fullname: Sinha
– volume: 7
  start-page: 1
  issue: 1
  year: 2017
  end-page: 11
  ident: CR39
  article-title: Psilocybin for treatment-resistant depression: FMRI-measured brain mechanisms
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-13282-7
  contributor:
    fullname: Carhart-Harris
– volume: 107
  start-page: 14811
  issue: 33
  year: 2010
  end-page: 14816
  ident: CR65
  article-title: Prefrontal-striatal pathway underlies cognitive regulation of craving
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1007779107
  contributor:
    fullname: Kober
– volume: 9
  start-page: 1
  year: 2018
  end-page: 7
  ident: CR32
  article-title: Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2018.00100
  contributor:
    fullname: Bogenschutz
– volume: 23
  start-page: 1289
  issue: 8
  year: 1999
  end-page: 1295
  ident: CR46
  article-title: Psychometric properties of the Penn Alcohol Craving Scale
  publication-title: Alcohol. Clin. Exp. Res.
  doi: 10.1111/j.1530-0277.1999.tb04349.x
  contributor:
    fullname: Pettinati
– ident: CR34
– year: 2020
  ident: CR41
  article-title: Emotions and brain function are altered up to one month after a single high dose of psilocybin
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-59282-y
  contributor:
    fullname: Gri
– volume: 78
  start-page: 922
  issue: 8
  year: 2021
  end-page: 924
  ident: CR13
  article-title: Use of medications for alcohol use disorder in the US: results from the 2019 National Survey on Drug Use and Health
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2021.1271
  contributor:
    fullname: Compton
– volume: 26
  start-page: 1
  issue: 1
  year: 2021
  end-page: 13
  ident: CR72
  article-title: Investigation of brain functional connectivity to assess cognitive control over cue-processing in alcohol use disorder
  publication-title: Addict. Biol.
  doi: 10.1111/adb.12863
  contributor:
    fullname: Strosche
– volume: 274
  start-page: 382
  year: 2014
  end-page: 389
  ident: CR55
  article-title: Neural correlates of a Go/NoGo task with alcohol stimuli in light and heavy young drinkers
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2014.08.039
  contributor:
    fullname: Ames
– volume: 12
  start-page: 1
  issue: 5
  year: 2020
  end-page: 23
  ident: CR8
  article-title: A day-by-day prospective analysis of stress, craving and risk of next day alcohol intake during alcohol use disorder treatment
  publication-title: Drug Alcohol Dependence.
  doi: 10.1016/j.drugalcdep.2019.107569.A
  contributor:
    fullname: Wemm
– volume: 29
  start-page: 289
  issue: 3
  year: 2015
  end-page: 299
  ident: CR15
  article-title: Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881114565144
  contributor:
    fullname: Strassman
– ident: CR62
– volume: 3
  start-page: 760
  issue: 8
  year: 2016
  end-page: 773
  ident: CR5
  article-title: Neurobiology of addiction: a neurocircuitry analysis
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(16)00104-8
  contributor:
    fullname: Volkow
– volume: 69
  start-page: 1060
  issue: 11
  year: 2011
  end-page: 1066
  ident: CR73
  article-title: Effects of cue-exposure treatment on neural cue reactivity in alcohol dependence: A randomized trial
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2010.12.016
  contributor:
    fullname: Vollstädt-Klein
– year: 2016
  ident: CR22
  article-title: Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881116675512
  contributor:
    fullname: Ross
– volume: 17
  start-page: 807
  issue: 4
  year: 2012
  end-page: 816
  ident: CR7
  article-title: Validating incentive salience with functional magnetic resonance imaging: Association between mesolimbic cue reactivity and attentional bias in alcohol-dependent patients
  publication-title: Addict. Biol.
  doi: 10.1111/j.1369-1600.2011.00352.x
  contributor:
    fullname: Vollstädt-Klein
– volume: 19
  start-page: 317
  issue: 3
  year: 2014
  end-page: 331
  ident: CR74
  article-title: The cerebellum and addiction: Insights gained from neuroimaging research
  publication-title: Addict. Biol.
  doi: 10.1111/adb.12101
  contributor:
    fullname: Borsook
– volume: 80
  start-page: 179
  issue: 3
  year: 2016
  ident: 52967_CR2
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2015.10.024
  contributor:
    fullname: LE Kwako
– volume: 1316
  start-page: 53
  issue: 1
  year: 2014
  ident: 52967_CR76
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/nyas.12415
  contributor:
    fullname: NH Naqvi
– volume: 235
  start-page: 399
  year: 2018
  ident: 52967_CR20
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-017-4771-x
  contributor:
    fullname: RL Carhart-Harris
– volume: 237
  start-page: 1161
  issue: 4
  year: 2020
  ident: 52967_CR30
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-019-05445-3
  contributor:
    fullname: A Murphy-Beiner
– ident: 52967_CR62
  doi: 10.1016/j.neuroimage.2009.10.088.Cognitive
– volume: 4
  start-page: 553
  issue: 2
  year: 2021
  ident: 52967_CR24
  publication-title: ACS Pharmacol. Transl. Sci.
  doi: 10.1021/acsptsci.1c00020
  contributor:
    fullname: S Ross
– ident: 52967_CR58
– volume: 93
  start-page: 270
  issue: 3
  year: 2009
  ident: 52967_CR66
  publication-title: Pharmacol. Biochem. Behav.
  doi: 10.1016/j.pbb.2008.12.009
  contributor:
    fullname: R Hester
– volume: 26
  start-page: 1
  issue: 1
  year: 2021
  ident: 52967_CR72
  publication-title: Addict. Biol.
  doi: 10.1111/adb.12863
  contributor:
    fullname: A Strosche
– volume: 15
  start-page: 1
  year: 2021
  ident: 52967_CR75
  publication-title: Front. Syst. Neurosci.
  doi: 10.3389/fnsys.2021.642225
  contributor:
    fullname: C Habas
– volume: 3
  start-page: 760
  issue: 8
  year: 2016
  ident: 52967_CR5
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(16)00104-8
  contributor:
    fullname: GF Koob
– volume: 25
  start-page: 1453
  issue: 11
  year: 2011
  ident: 52967_CR27
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881111420188
  contributor:
    fullname: KA MacLean
– year: 2019
  ident: 52967_CR80
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aaw4358
  contributor:
    fullname: PA Kragel
– volume: 56
  start-page: 101809
  year: 2023
  ident: 52967_CR18
  publication-title: eClinicalMedicine
  doi: 10.1016/j.eclinm.2022.101809
  contributor:
    fullname: R von Rotz
– volume: 129
  start-page: 544
  issue: 6
  year: 2020
  ident: 52967_CR56
  publication-title: J. Abnorm. Psychol.
  doi: 10.1037/abn0000503
  contributor:
    fullname: JA Mollick
– ident: 52967_CR44
– volume: 29
  start-page: 289
  issue: 3
  year: 2015
  ident: 52967_CR15
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881114565144
  contributor:
    fullname: MP Bogenschutz
– volume: 70
  start-page: 727
  issue: 7
  year: 2013
  ident: 52967_CR60
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.762
  contributor:
    fullname: D Seo
– volume: 274
  start-page: 382
  year: 2014
  ident: 52967_CR55
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2014.08.039
  contributor:
    fullname: SL Ames
– volume: 41
  start-page: 1
  issue: 1
  year: 2021
  ident: 52967_CR14
  publication-title: Alcohol Res. Curr. Rev.
  doi: 10.35946/arcr.v41.1.07
  contributor:
    fullname: BJ Mason
– volume: 12
  start-page: 1
  year: 2021
  ident: 52967_CR31
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2021.721537
  contributor:
    fullname: MK Kiraga
– volume: 7
  start-page: 1
  issue: 10
  year: 2012
  ident: 52967_CR77
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0046931
  contributor:
    fullname: E Beraha
– volume: 17
  start-page: 807
  issue: 4
  year: 2012
  ident: 52967_CR7
  publication-title: Addict. Biol.
  doi: 10.1111/j.1369-1600.2011.00352.x
  contributor:
    fullname: S Vollstädt-Klein
– volume: 69
  start-page: 1060
  issue: 11
  year: 2011
  ident: 52967_CR73
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2010.12.016
  contributor:
    fullname: S Vollstädt-Klein
– year: 2018
  ident: 52967_CR81
  publication-title: Front. Hum. Neurosci.
  doi: 10.3389/fnhum.2018.00448
  contributor:
    fullname: AA Magalhaes
– volume: 44
  start-page: 679
  issue: 3
  year: 2020
  ident: 52967_CR3
  publication-title: Alcohol. Clin. Exp. Res.
  doi: 10.1111/acer.14283
  contributor:
    fullname: VR Votaw
– year: 2022
  ident: 52967_CR79
  publication-title: Nat. Neurosci.
  doi: 10.1038/s41593-022-01228-w
  contributor:
    fullname: L Koban
– volume: 1
  start-page: 493
  year: 2005
  ident: 52967_CR1
  publication-title: Annu. Rev. Clin. Psychol.
  doi: 10.1146/annurev.clinpsy.1.102803.144107
  contributor:
    fullname: KJ Sher
– volume: 15
  start-page: 80
  year: 2017
  ident: 52967_CR67
  publication-title: NeuroImage Clin.
  doi: 10.1016/j.nicl.2017.04.010
  contributor:
    fullname: SB Beylergil
– volume: 92
  start-page: 55
  issue: 1–3
  year: 2008
  ident: 52967_CR68
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2007.06.011
  contributor:
    fullname: PS Boggio
– volume: 23
  start-page: 1289
  issue: 8
  year: 1999
  ident: 52967_CR46
  publication-title: Alcohol. Clin. Exp. Res.
  doi: 10.1111/j.1530-0277.1999.tb04349.x
  contributor:
    fullname: BA Flannery
– volume: 26
  start-page: 155
  issue: 3
  year: 2023
  ident: 52967_CR69
  publication-title: Int. J. Neuropsychopharmacol.
  doi: 10.1093/ijnp/pyac074
  contributor:
    fullname: JJ Gattuso
– volume: 196
  start-page: 207
  year: 2019
  ident: 52967_CR37
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2019.04.009
  contributor:
    fullname: L Smigielski
– year: 2017
  ident: 52967_CR38
  publication-title: Transl. Psychiatry
  doi: 10.1038/tp.2017.40
  contributor:
    fullname: T Wise
– volume: 14
  start-page: 1
  issue: June
  year: 2023
  ident: 52967_CR36
  publication-title: Front. Psychol.
  doi: 10.3389/fpsyg.2023.1104627
  contributor:
    fullname: J Kähönen
– ident: 52967_CR50
  doi: 10.1101/2023.08.22.23294131
– volume: 8
  start-page: 1
  issue: 1
  year: 2018
  ident: 52967_CR82
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-28274-4
  contributor:
    fullname: M Fujino
– volume: 113
  start-page: 220
  issue: 2
  year: 2018
  ident: 52967_CR11
  publication-title: Addiction
  doi: 10.1111/add.13974
  contributor:
    fullname: C Palpacuer
– volume: 105
  start-page: 1741
  issue: 10
  year: 2010
  ident: 52967_CR47
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2010.03022.x
  contributor:
    fullname: S Vollstädt-Klein
– volume: 159
  start-page: 70
  year: 2017
  ident: 52967_CR51
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2017.07.020
  contributor:
    fullname: L Cr
– volume: 141
  start-page: 124
  year: 2014
  ident: 52967_CR63
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2014.05.017
  contributor:
    fullname: SM Kim
– volume: 5
  start-page: 239
  issue: 2
  year: 2020
  ident: 52967_CR64
  publication-title: Biol. Psychiatry Cogn. Neurosci. Neuroimaging
  doi: 10.1016/j.bpsc.2019.10.005
  contributor:
    fullname: S Suzuki
– volume: 30
  start-page: 398
  issue: 4
  year: 2021
  ident: 52967_CR35
  publication-title: Am. J. Addict.
  doi: 10.1111/ajad.13170
  contributor:
    fullname: LA Keyser-Marcus
– volume: 45
  start-page: 1200
  issue: 6
  year: 2021
  ident: 52967_CR6
  publication-title: Alcohol. Clin. Exp. Res.
  doi: 10.1111/acer.14614
  contributor:
    fullname: K Al-Khalil
– volume: 311
  start-page: 1889
  issue: 18
  year: 2014
  ident: 52967_CR12
  publication-title: JAMA
  doi: 10.1001/jama.2014.3628
  contributor:
    fullname: DE Jonas
– year: 2023
  ident: 52967_CR78
  publication-title: Psychol. Addict. Behav.
  doi: 10.1037/adb0000935
  contributor:
    fullname: G Agin-Liebes
– volume: 107
  start-page: 14811
  issue: 33
  year: 2010
  ident: 52967_CR65
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1007779107
  contributor:
    fullname: H Kober
– year: 2016
  ident: 52967_CR22
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881116675512
  contributor:
    fullname: S Ross
– volume: 11
  start-page: 1
  issue: 1
  year: 2021
  ident: 52967_CR28
  publication-title: Transl. Psychiatry
  doi: 10.1038/s41398-021-01706-y
  contributor:
    fullname: MK Doss
– volume: 31
  start-page: 440
  issue: 1
  year: 2006
  ident: 52967_CR61
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2005.12.002
  contributor:
    fullname: G Northoff
– year: 2020
  ident: 52967_CR41
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-59282-y
  contributor:
    fullname: FS Barrett
– volume: 13
  start-page: 1
  issue: 1
  year: 2020
  ident: 52967_CR83
  publication-title: Mol. Brain
  doi: 10.1186/s13041-020-00605-5
  contributor:
    fullname: A Ju
– volume: 387
  start-page: 1637
  issue: 18
  year: 2022
  ident: 52967_CR19
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2206443
  contributor:
    fullname: GM Goodwin
– volume: 7
  start-page: 1
  issue: 1
  year: 2017
  ident: 52967_CR39
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-13282-7
  contributor:
    fullname: RL Carhart-Harris
– volume: 18
  start-page: 121
  issue: 1
  year: 2013
  ident: 52967_CR53
  publication-title: Addict. Biol.
  doi: 10.1111/j.1369-1600.2012.00464.x
  contributor:
    fullname: JP Schacht
– ident: 52967_CR33
– volume: 18
  start-page: 593
  issue: 3
  year: 2013
  ident: 52967_CR71
  publication-title: Addict. Biol.
  doi: 10.1111/adb.12013
  contributor:
    fullname: KE Courtney
– volume: 54
  start-page: 167
  issue: 2
  year: 2019
  ident: 52967_CR9
  publication-title: Alcohol Alcohol.
  doi: 10.1093/alcalc/agy093
  contributor:
    fullname: ME Stohs
– volume: 72
  start-page: 898
  issue: 11
  year: 2012
  ident: 52967_CR17
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2012.04.005
  contributor:
    fullname: M Kometer
– year: 2016
  ident: 52967_CR21
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881116675513
  contributor:
    fullname: RR Griffiths
– ident: 52967_CR49
  doi: 10.56441/hilbertpress.2207.6600
– volume: 78
  start-page: 922
  issue: 8
  year: 2021
  ident: 52967_CR13
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2021.1271
  contributor:
    fullname: B Han
– volume: 34
  start-page: 167
  issue: 2
  year: 2020
  ident: 52967_CR40
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881119895520
  contributor:
    fullname: LJ Mertens
– volume: 9
  start-page: 1
  year: 2018
  ident: 52967_CR32
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2018.00100
  contributor:
    fullname: MP Bogenschutz
– volume: 1
  start-page: 3
  issue: 39–58
  year: 1997
  ident: 52967_CR48
  publication-title: NIMH Cent. Study Emot. Atten.
  contributor:
    fullname: PJ Lang
– year: 2022
  ident: 52967_CR16
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2022.2096
  contributor:
    fullname: MP Bogenschutz
– volume: 28
  start-page: 983
  issue: 11
  year: 2014
  ident: 52967_CR23
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881114548296
  contributor:
    fullname: MW Johnson
– ident: 52967_CR34
– volume: 57
  start-page: 389
  issue: 4
  year: 2017
  ident: 52967_CR43
  publication-title: J. Humanist. Psychol.
  doi: 10.1177/0022167816673493
  contributor:
    fullname: MP Bogenschutz
– volume: 128
  start-page: 294
  year: 2021
  ident: 52967_CR52
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2021.06.031
  contributor:
    fullname: J Zeng
– volume: 35
  start-page: 48
  issue: 1
  year: 2010
  ident: 52967_CR70
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2009.131
  contributor:
    fullname: BW Balleine
– volume: 82
  start-page: 251
  issue: 3
  year: 2022
  ident: 52967_CR10
  publication-title: Drugs
  doi: 10.1007/s40265-021-01670-3
  contributor:
    fullname: EM Burnette
– volume: 83
  start-page: S231
  issue: 9
  year: 2018
  ident: 52967_CR29
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2018.02.600
  contributor:
    fullname: M McKenna
– volume: 113
  start-page: 492
  issue: March
  year: 2020
  ident: 52967_CR4
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2020.04.004
  contributor:
    fullname: V Voon
– year: 2022
  ident: 52967_CR42
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2022.884703
  contributor:
    fullname: D Perkins
– volume: 177
  start-page: 1048
  issue: 11
  year: 2020
  ident: 52967_CR59
  publication-title: Am. J. Psychiatry
  doi: 10.1176/appi.ajp.2020.19070703
  contributor:
    fullname: SK Blaine
– volume: 163
  start-page: S25
  year: 2016
  ident: 52967_CR54
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2015.10.036
  contributor:
    fullname: DS Chester
– volume: 19
  start-page: 317
  issue: 3
  year: 2014
  ident: 52967_CR74
  publication-title: Addict. Biol.
  doi: 10.1111/adb.12101
  contributor:
    fullname: EA Moulton
– volume: 138
  start-page: 368
  issue: 5
  year: 2018
  ident: 52967_CR26
  publication-title: Acta Psychiatr. Scand.
  doi: 10.1111/acps.12904
  contributor:
    fullname: D Erritzoe
– year: 2022
  ident: 52967_CR57
  publication-title: Brain Cogn.
  doi: 10.1016/j.bandc.2022.105843
  contributor:
    fullname: I Kinley
– volume: 12
  start-page: 1
  issue: 5
  year: 2020
  ident: 52967_CR8
  publication-title: Drug Alcohol Dependence.
  doi: 10.1016/j.drugalcdep.2019.107569.A
  contributor:
    fullname: SE Wemm
– year: 2020
  ident: 52967_CR25
  publication-title: Psychol. Med.
  doi: 10.1017/S003329172000389X
  contributor:
    fullname: SB Goldberg
– ident: 52967_CR45
SSID ssj0000529419
Score 2.4824305
Snippet This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder (AUD)....
Abstract This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder...
Abstract This pilot study investigated psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 3159
SubjectTerms 631/1647/245/1627
631/378/3920
692/308/2779/777
Alcohol use
Alcohols
Brain mapping
Cerebellum
Clinical trials
Cortex (parietal)
Diphenhydramine
Emotions
Functional magnetic resonance imaging
Hippocampus
Humanities and Social Sciences
Magnetic resonance imaging
multidisciplinary
NCT
NCT02061293
Neuroimaging
Occipital lobe
Patients
Pilot projects
Prefrontal cortex
Psilocybin
Science
Science (multidisciplinary)
Temporal lobe
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEC5kQfAivm1dJYI3DXZenbQ3FZdVWBFxYW8hT5xLz7Ldc9h_4M-20ukZd3zgxWN3ErpIVbq-SlJfATxvc_JaqExdFIrK2AeKz4FKpot_5MyzkuB88qk7PpUfz9TZlVJf5U5YpQeuE4cBuzPoR3zuopPeeYNhT-x86IPOPLvKXtr2V4KpyurNe8n6JUumFebViJ6qZJNxSctRI_6a9zzRTNj_J5T5-2XJX05MZ0d0dAtuLgiSvKmS34ZrabgD12tNycu78P3zuEIHdYkRL8V4GzUXSc3uHclqIIW_EkcjVAy1bgSZ1sTVOrnEDZGkWtcH-4RNHbJQr46k7Nnu-m7GROJC3fkaR5J88uUDOcdvT2TmrL0Hp0fvv747pku5BRqUZBNVRnvFpeEisJz7NjjR5WBCdsnpEBJnwoegRBfbEDPTuu1mvWTJPM8siftwMKyH9BBIV3ZSvOuNQnSJMZkL3ieEWojuFAK-1MCL7dTb88qqYefTcGFsVZRFRdlZUdY08LZoZ9ezMGLPL9BO7GIn9l920sDhVrd2Waaj5QXeGoyAdQPPds24wMqpiRvSelP79EWyroEH1RR2kmB4j4BS8AbMnpHsibrfMqy-zSTeJeujMCM18HJrTz_l-vtcPPofc_EYbvCyEMrlc30IB9PFJj1BbDX5p_My-gFiSyOV
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9QwDI5gERIXxJvCgoLEDaptkqZJuSBArBakRQix0tyiJE1gLu2w7Rz2H_CzsZNOV8Pr2DZR3dqJP9uxTcjzKganhIyl7YQs6671JVz7smYK9SNnjmGC8-mn5uSs_riSq9nhNs7HKnd7Ytqou8Gjj_yIIxLRYKyo15sfJXaNwujq3ELjKrnGeNXgkS61UouPBaNYNWvnXJlK6KMR9BXmlPG6xIAjbNB7-iiV7f8b1vzzyORvcdOkjo5vkZszjqRvMuNvkyuhv0Ou586SF3fJz8_jGtTUBdi9JVjdwL-O5hzfka57ilUsYTYARp-7R9BpoDZ3y6W272jI3X1gjN_mKXMB1pGi53YZux0D7eYCnq9gJo2nXz7QDbx7oqly7T1ydvz-67uTcm66UHpZs6mUWjnJa82FZzG2lbeiiV77aINV3gfOhPNeiqarfBeZUlXDaxebWDPHIwviPjnohz48JLRBf4qzrZaAMcEys965AIALMJ4E2BcK8mL3680m19YwKSYutMmMMsAokxhldEHeIneWkVgXO90Yzr-ZeZkZqayuEj2drZ11GozkrnG-9SryaGVBDne8NfNiHc2laBXk2fIYlhnGTmwfhm0e0yJlTUEeZFFYKAEjH2Cl4AXRe0KyR-r-k379PZXyxtwPrI9UkJc7ebqk69__4tH_P-MxucFRxPFwuTokB9P5NjwB7DS5p2mB_AJuQxm_
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BERIX1PJMW5CRuEFE_IodbrBqVZCKEKJSb5bt2GIv2YpkD_0H_OyO42xQoBw47masHWXGO994PN8AvK5icIrLWNqWy1K0jS_xsy8FVSk-MupoanA-_1KfXYjPl_JyoslJvTCL-j3X73oMMKkJjIkyVQjxH_Uu3MMYrNP1rVW9ms9TUsVK0Gbqi7l96SL2jBT9t-HKv69H_lEjHUPP6T48nDAj-ZCNfAB3QvcI7ucpkteP4dfXfo0h6Rpz3BIzbLRVS3I_b0_WHUmMlbgawaHPkyLIsCE2T8YltmtJyJN8UMZv85KJbLUn6ZR2lt32gbQTWed7XEni-bdP5Ap_eyAjS-0TuDg9-b46K6cBC6WXgg6l1MpJJjTjnsbYVN7yOnrtow1WeR8Y5c57yeu28m2kSlU1Ey7WUVDHIg38Kex1my48B1KnsxNnGy0RT2IWZr1zAcEV4jmJEC8U8Gb36s1V5tEwY_2ba5MNZdBQZjSU0QV8TNaZJRMH9vgFuoaZtpSRyupq1Ke1wlmnMSFua-cbryKLVhZwvLOtmTZmb1gCtBpzXlXAq_kxbqlUJ7Fd2GyzTJM0qwt4ll1h1gQTeoSQnBWgF06yUHX5pFv_GGm7U59H4kIq4O3On37r9e93cfh_4kfwgCWXTxfL1THsDT-34QXipsG9HDfMDU13EtM
  priority: 102
  providerName: Springer Nature
Title Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study
URI https://link.springer.com/article/10.1038/s41598-024-52967-8
https://www.ncbi.nlm.nih.gov/pubmed/38326432
https://www.proquest.com/docview/2923181077
https://search.proquest.com/docview/2923910386
https://pubmed.ncbi.nlm.nih.gov/PMC10850478
https://doaj.org/article/57a8024bf6da4bab8978d6bc9c7f2fa5
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61RaBeEG8CZWUkbpBuYsexw42uWhWkrVYVlfYW2Y4NK9Hsqtk99B_wsxnbycLyuHBMYiujzEz8jT3zDcCbzFktGHepahhPi6YyKV6btMiFXx9prnNf4Dy9KM-vik9zPt-DcqiFCUn7Ri-O22_Xx-3ia8itXF2b8ZAnNp5NJz5j3rPKjPdhHy30lxg9MnrTqsirvkImY3Lc4SrlK8lokfpjRvwtH8I9DM0QDDC6syAF3v6_gc0_cyZ_OzgN69HZA7jfA0nyIQr8EPZs-wjuxtaSt4_h-6xb4Dp1i4FvimE3KrAhsci3I4uWeBpLnI2I0cT2EWS9JCq2yyWqbYiN7X1wjNnEKT0Da0f81u127KazpOkZPN_jTOKmlx_JCt-9JoG69glcnZ1-npynfdeF1PAiX6dcCs1pISkzuXNVZhQrnZHGKauEMZbmTBvDWdlkpnG5EFlJC-1KV-Sautyyp3DQLlv7HEjpN1S0qiRHkImhmTJaW0RcCPI44j6bwNvh09erSK5Rh0NxJuuosxp1Vged1TKBE6-d7UhPjB1uLG--1L151FwomQV5GlVopSVGyU2pTWWEo07xBI4G3da9t3Y19ShXYiAsEni9fYx-5g9PVGuXmzim8pKVCTyLprCVZDClBOSOkeyIuvsETTtweQ-mnMC7wZ5-yvXvb_Hi_9_0Eg6p9wSfeS6O4GB9s7GvEFit9Qi9aS5GcOfk9GJ2iVeTcjIKmxSj4GE_AChUJ24
link.rule.ids 230,315,730,783,787,867,888,2109,12068,21400,27936,27937,31731,31732,33756,33757,41132,42201,43322,43817,51588,53804,53806,74073,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgEYIL4k1gASNxg2hjJ44dLggQqy5sVwjtSr1ZtmNDL2nZpIf9B_xsZuw0q_I6trFVNzP2fDPj-YaQl0XwVpYi5KYtRV61jcvhs8srJtE-cmYZFjjPT-rZWfVpIRZjwK0fr1Vuz8R4ULcrhzHyA45IRIGzIt-uf-TYNQqzq2MLjavkGvJwYQcDuZBTjAWzWBVrxlqZolQHPdgrrCnjVY4JRzigd-xRpO3_G9b888rkb3nTaI4Ob5NbI46k75Lg75ArvrtLrqfOkhf3yM8v_RLM1AX4vTl43SC_lqYa354uO4osljAbAKNL3SPosKImdculpmupT919YIzbpCkjAWtPMXI7jd30nrYjgecbmEnD_OsRXcNvDzQy194nZ4cfTz_M8rHpQu5ExYZcKGkFrxQvHQuhKZwp6-CUC8Yb6ZznrLTOibJuC9cGJmVR88qGOlTM8sB8-YDsdavOPyK0xniKNY0SgDHBMzPOWg-ACzCeANjnM_Jq--r1OnFr6JgTL5VOgtIgKB0FpVVG3qN0ppHIix2_WJ1_0-M200IaVcT1tKayxipwktvausbJwIMRGdnfylaPm7XXl6qVkRfTY9hmmDsxnV9t0pgGV1Zn5GFShWkl4OQDrCx5RtSOkuwsdfdJt_weqbyx9gP5kTLyeqtPl-v697t4_P-_8ZzcmJ3Oj_Xx0cnnJ-QmR3WPF833yd5wvvFPAUcN9lncLL8AuxEcoA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELagKxAXxJvAAkbiBlETP2KHC2Jhq11gq2rFSnuzbMeGXpKySQ_7D_jZjGO3q_I6trHVaWbG843nhdCrwjsjKPe5bijPWVPbHD7bnJUi2EdSmjIUOJ_Mq6Mz9umcn6f8pz6lVW7OxPGgbjob7sinJCARCc6KmPqUFrH4OHu3-pGHCVIh0prGaVxHe4JVtJigvYPD-eJ0e-MSYlqsrFPlTEHltAfrFSrMCMtD-BGO6x3rNDbx_xvy_DOB8rco6micZnfQ7YQq8fsoBnfRNdfeQzfinMnL--jnol-C0boELzgHHxy42eBY8dvjZYtDT0vYDfDRxlkSeOiwjrNzsW4b7OKsH1hj13FLasfa43CPu1277h1uUjvPt7AT-5PTY7yC3x7w2Mf2ATqbHX79cJSnEQy55awcci6F4YRJQm3pfV1YTStvpfXaaWGtIyU11nJaNYVtfClEURFmfOVZaYgvHX2IJm3XuscIV-F2xehackCc4Kdpa4wD-AWIjwMIdBl6vXn1ahU7bagxQk6lioxSwCg1MkrJDB0E7mxXhi7Z4xfdxTeVlE5xoWUx0tNoZrSR4DI3lbG1FZ54zTO0v-GtSqrbqytBy9DL7WNQuhBJ0a3r1nFNHSirMvQoisKWEnD5AWRSkiG5IyQ7pO4-aZffx8beoRIkdEvK0JuNPF3R9e938eT_f-MFugmaor4czz8_RbdIkPaQdS720WS4WLtnAKoG8zxpyy_r0yJD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psilocybin-induced+changes+in+neural+reactivity+to+alcohol+and+emotional+cues+in+patients+with+alcohol+use+disorder%3A+an+fMRI+pilot+study&rft.jtitle=Scientific+reports&rft.au=Pagni%2C+B+A&rft.au=Petridis%2C+P+D&rft.au=Podrebarac%2C+S+K&rft.au=Grinband%2C+J&rft.date=2024-02-07&rft.eissn=2045-2322&rft.volume=14&rft.issue=1&rft.spage=3159&rft.epage=3159&rft_id=info:doi/10.1038%2Fs41598-024-52967-8&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon